OCX - OncoCyte GAAP EPS of $0.04 beats by $0.13 revenue of $0.3M misses by $0.04M May, 11 2023 08:06 AM Oncocyte Corporation 2023-05-11 08:06:35 ET OncoCyte press release ( NASDAQ: OCX ): Q1 GAAP EPS of $0.04 beats by $0.13 . Revenue of $0.3M (-21.1% Y/Y) misses by $0.04M . For further details see: OncoCyte GAAP EPS of $0.04 beats by $0.13, revenue of $0.3M misses by $0.04M